Xanthine Oxidase Inhibition by Febuxostat Attenuates Experimental Atherosclerosis in Mice

Nomura, Johji, Busso, Nathalie, Ives, Annette, Matsui, Chieko, Tsujimoto, Syunsuke, Shirakura, Takashi, Tamura, Mizuho, Kobayashi, Tsunefumi +2 more·2014·Scientific Reports
DOI 10.1038/srep04554

Cited by (181)

Items 101–181 of 181

  1. Expression and role of interleukin‑1β and associated biomarkers in deep vein thrombosis
    Rouzimaimaiti Pai, Qingbo Fang, Guanglei Tian, Bing Zhu, Xiaohu Ge · 2021 · Experimental and Therapeutic Medicine
  2. Allopurinol Lowers Serum Urate but Does Not Reduce Oxidative Stress in CKD
    Mingyao Sun, Nicole G. Hines, Diego A. Scerbo, Jane L. Buchanan, Chaorong Wu, Patrick Ten Eyck, Diana Zepeda‐Orozco, Eric B. Taylor, Diana I. Jalal · 2022 · Antioxidants
  3. Xanthine oxidase inhibitor febuxostat reduces atrial fibrillation susceptibility by inhibition of oxidized CaMKII in Dahl salt-sensitive rats
    Dongzhu Xu, Nobuyuki Murakoshi, Kazuko Tajiri, Feng Duo, Yuta Okabe, Yoshiko Murakata, Zixun Yuan, Siqi Li, Kazuhiro Aonuma, Zonghu Song et al. · 2021 · Clinical Science
  4. Xanthine Oxidoreductase in the Pathogenesis of Endothelial Dysfunction: An Update
    Rajat Kumar Mudgal, Sanjiv Singh · 2024 · Current Hypertension Reviews
  5. Pleiotrophin-induced endothelial cell migration is regulated by xanthine oxidase-mediated generation of reactive oxygen species
    Sotiria Tsirmoula, Μαργαρίτα Λάμπρου, Maria Hatziapostolou, Nelly Kieffer, Εvangelia Papadimitriou · 2015 · Microvascular Research
  6. Association between long-term prescription of febuxostat and the progression of heart failure with preserved ejection fraction in patients with hypertension and asymptomatic hyperuricemia
    Jianan Pan, Hao Lin, Changqian Wang, Junfeng Zhang, Jun Gu · 2020 · Heart and Vessels
  7. Revisão crítica do tratamento medicamentoso da gota no Brasil
    Valderílio Feijó Azevedo, Maicon Piana Lopes, Nathan Marostica Catolino, Eduardo dos Santos Paiva, Vitor Andrei Araújo, Geraldo da Rocha Castelar Pinheiro · 2017 · Revista Brasileira de Reumatologia
  8. Allopurinol does not improve cardiovascular outcomes in ischaemic heart disease
    Giovanna Liuzzo, Carlo Patrono · 2023 · European Heart Journal
  9. Cardiovascular safety of febuxostat. Analysis of the CARES study
    М. С. Елисеев · 2018 · Modern Rheumatology Journal
  10. Targeting Reactive Oxygen Species in Atherosclerosis via Chinese Herbal Medicines
    Leyi Zhang, Jiaqin Huang, Danli Zhang, Xiaojing Lei, Yan Ma, Yun Cao, Jingling Chang · 2022 · Oxidative Medicine and Cellular Longevity
  11. Bioactive natural products as potent inhibitors of xanthine oxidase
    Prathapan Ayyappan, Suresh V. Nampoothiri · 2020 · Studies in natural products chemistry
  12. PTEN/PI3K/VEGF signaling pathway involved in the protective effect of xanthine oxidase inhibitor febuxostat against endometrial hyperplasia in rats
    Mervat Z. Mohamed, Mohamed F. Abed El Baky, OA Hassan, HH Mohammed, Asmaa Mohamed Abdel‐Aziz · 2020 · Human & Experimental Toxicology
  13. Protective effect of α–lipoic acid against spleen toxicity of dimethylnitrosamine in male mice: Antioxidant and ultrastructure approaches
    Nahla S. El‐Shenawy, Reham Z. Hamza, Howayda E. Khaled · 2017 · Biomedicine & Pharmacotherapy
  14. Anti-EMT properties of ergothioneine attenuate lipopolysaccharide-induced oxidative stress-mediated acute lung injury via modulating TGF-β/smad/snail signaling pathway
    Shabnoor Iqbal, Farhat Jabeen, Noman Aslam, Maria Manan · 2023 · Human & Experimental Toxicology
  15. Reno-protective effect of fenofibrate and febuxostat against vancomycin-induced acute renal injury in rats: Targeting PPARγ/NF-κB/COX-II and AMPK/Nrf2/HO-1 signaling pathways
    Ehab A. M. El‐Shoura, Souty M.Z. Sharkawi, Lobna A. Abdelzaher, Basel A. Abdel-Wahab, Yasmine H. Ahmed, Asmaa Ramadan Abdel-Sattar · 2024 · Immunopharmacology and Immunotoxicology
  16. Febuxostat inhibits TGF‑β1‑induced epithelial‑mesenchymal transition via downregulation of USAG‑1 expression in Madin‑Darby canine kidney cells in�vitro
    Linghong Lu, Jiajun Zhu, Yaqian Zhang, Yanxia Wang, Shu Zhang, Anzhou Xia · 2019 · Molecular Medicine Reports
  17. Xiaoyaosan prevents atherosclerotic vulnerable plaque formation through heat shock protein/glucocorticoid receptor axis-mediated mechanism.
    Wenjun Fu, Mingtai Chen, Lijun Ou, Tao Li, Xiao Chang, Ruolan Huang, Jian Zhang, Zhong Zhang · 2019 · PubMed Central
  18. Effective xanthine oxidase inhibitor urate lowering therapy in gout is linked to an emergent serum protein interactome of complement and inflammation modulators
    Concepcion Sanchez, Anaamika Campeau, Ru Liu‐Bryan, Ted R. Mikuls, James R. O’Dell, David J. Gonzalez, Robert A. Terkeltaub · 2024 · Scientific Reports
  19. Proteoglycan 4 (Lubricin) and regulation of xanthine oxidase in synovial macrophage as a mechanism of controlling synovitis
    Khaled A. Elsaid, Ling X. Zhang, Thomas Zhao, Ava J. Marks, Derek Jenkins, Tannin A. Schmidt, Gregory D. Jay · 2024 · Arthritis Research & Therapy
  20. The role of hyperuricemia in the progression of end‐stage kidney disease and its molecular prospective in inflammation and cardiovascular diseases: A general review
    Yousuf Abdulkarim Waheed, Jie Liu, Shifaa Almayahe, Dong Sun · 2025 · Therapeutic Apheresis and Dialysis
  21. XOR inhibition with febuxostat accelerates pulmonary endothelial barrier recovery and improves survival in lipopolysaccharide-induced murine sepsis
    Mahendra Damarla, Laura Johnston, Gigi Yuen-Gee Liu, Li Gao, Lan Wang, Lidenys Varela, Todd M. Kolb, Bo Kim, Rachel L. Damico, Paul M. Hassoun · 2017 · Physiological Reports
  22. Febuxostat attenuates vascular calcification induced by vitamin D3 plus nicotine in rats
    Ahmed E. Amer, Ahmed R. El‐Sheakh, Mohamed F. Hamed, Hassan A. El‐Kashef, Manar A. Nader, George S.G. Shehatou · 2020 · European Journal of Pharmaceutical Sciences
  23. Influence of dexamethasone-induced stress on oxidative stress biomarkers in non-pregnant does experimentally infected with Brucella melitensis
    Polycarp Nwunuji Tanko, Sabri Mohd Yusoff, Benjamin Obukowho Emikpe, Salisi M. Shahrom, Bejo Siti-Khairani · 2017 · Comparative Clinical Pathology
  24. Critical revision of the medical treatment of gout in Brazil
    Valderílio Feijó Azevedo, Maicon Piana Lopes, Nathan Marostica Catolino, Eduardo dos Santos Paiva, Vitor Andrei Araújo, Geraldo da Rocha Castelar Pinheiro · 2017 · Revista Brasileira de Reumatologia (English Edition)
  25. The molecular interplay among gut dysbiosis, adipose tissue, and metabolite-derived damage-associated molecular patterns in metainflammation and atherogenesis
    Leslie-Marisol González-Hermosillo, Karol Iliana Avila-Soto, Lucía Angélica Méndez-García, Arturo Cérbulo‐Vázquez, Marcela Esquivel‐Velázquez, Nallely Bueno-Hernández, Miguel A. Fonseca-Sánchez, Galileo Escobedo · 2025 · Frontiers in Immunology
  26. Synthesis, Biological Evaluation, and Molecular Docking Studies of Hydrazones as Novel Xanthine Oxidase Inhibitors
    Ling‐Wei Xue, Shitong Li, Yong-Jun Han, Xiao-Qiang Luo · 2022 · Acta chimica slovenica
  27. Platycodin D Improves Early Atherosclerosis in Type 2 Diabetes Mellitus by Regulating Endothelial Inflammation and Apoptosis
    Zi Wang, Yu Dong, Yu-Ying Bai, Jing-Tian Zhang, Leqi Wang, Shen Ren, Xin‐Dian Li, Junnan Hu, Wei Li · 2025 · The American Journal of Chinese Medicine
  28. Purine Metabolite Signatures and Type 2 Diabetes: Innocent Bystanders or Actionable Items?
    Giulio R. Romeo, Meenu Jain · 2020 · Current Diabetes Reports
  29. Association between serum urate level and carotid atherosclerosis: an insight from a post hoc analysis of the PRIZE randomised clinical trial
    Atsushi Tanaka, Shigeru Toyoda, Toru Kato, Hisako Yoshida, Shuichi Hamasaki, Masato Watarai, Tomoko Ishizu, Shinichiro Ueda, Teruo Inoue, Koichi Node · 2022 · RMD Open
  30. Extracellular Purine Metabolism—Potential Target in Multiple Sclerosis
    Danijela Laketa, Irena C. Lavrnja · 2024 · Molecular Neurobiology
  31. Narrative Review: Peripheral Arterial Disease in Patients with Hyperuricemia and Gout
    N. Leung, C. Fang, J. Pendse, M. Toprover, M. Pillinger · 2023 · Current Rheumatology Reports
  32. Alcohol abuse is associated with enhanced pulmonary and systemic xanthine oxidoreductase activity
    Mehdi A. Fini, Jeanette Gaydos, Alicia McNally, Vijaya Karoor, Ellen Lyda Burnham · 2017 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  33. XOR-Derived ROS in Tie2-Lineage Cells Including Endothelial Cells Promotes Aortic Aneurysm Progression in Marfan Syndrome
    Hiroki Yagi, Hiroshi Akazawa, Qing Liu, Kimiko Yamamoto, Kan Nawata, Akiko Saga-Kamo, Masahiko Umei, Hiroshi Kadowaki, Ryo Matsuoka, Akito Shindo et al. · 2025 · Arteriosclerosis Thrombosis and Vascular Biology
  34. Allopurinol, Febuxostat, and Nonuse of Xanthine Oxidoreductase Inhibitor Treatment in Patients Receiving Hemodialysis: A Longitudinal Analysis
    Takeo Ishii, Nodoka Seya, Masataka Taguri, Hiromichi Wakui, Ashio Yoshimura, Kouichi Tamura · 2024 · Kidney Medicine
  35. Antioxidants in Cardiovascular Health: Implications for Disease Modeling Using Cardiac Organoids
    Gracious R. Ross, Ivor J. Benjamin · 2025 · Antioxidants
  36. Febuxostat reduces muscle wasting in tumor-bearing mice with LM8 osteosarcoma cells via inhibition of reactive oxygen species generation
    Tadashi Tsukamoto, Masaya Tsujii, Kazuya Odake, Takahiro Iino, Tomoki Nakamura, Akihiko Matsumine, Akihiro Sudo · 2021 · Free Radical Research
  37. Febuxostat mitigates IL-18-induced inflammatory response and reduction of extracellular matrix gene.
    Qin Geng, Hongju Zhang, Yanhui Cui, Qiaofeng Wei, Shujun Wang · 2021 · PubMed Central
  38. Effect of the Xanthine Oxidase Inhibitor Febuxostat on the Cardio-Ankle Vascular Index in Asymptomatic Patients with Hyperuricemia and Liver Dysfunction: A Sub-Analysis of the PRIZE Study
    Yusuke Kawachi, Yuya Fujishima, Hitoshi Nishizawa, Atsushi Tanaka, Hisako Yoshida, Shinichi Niwano, Makoto Suzuki, Iichiro Shimomura, Koichi Node · 2024 · Journal of Atherosclerosis and Thrombosis
  39. Studies on the Effects of Hypercholesterolemia on Mouse Ophthalmic Artery Reactivity
    Francesco Buonfiglio, Ning Xia, Can Yüksel, Caroline Manicam, Subao Jiang, Jenia Kouchek Zadeh, Aytan Musayeva, Eva Elksne, Norbert Pfeiffer, Andreas Reinhold Patzak et al. · 2023 · Diseases
  40. Amelioration of Citrobacter rodentium proliferation in early stage of infection in mice by pre-treatment with Lactobacillus brevis KB290 and verification using in vivo bioluminescence imaging
    Naoko Waki, Yuki Kuwabara, Yuko Yoshikawa, Hiroyuki Suganuma, Hiroyuki Koide, Naoto Oku, Norio Ohashi · 2016 · FEMS Microbiology Letters
  41. Role of Oxidative Stress and Cardiovascular Risk Factors in Ischemic Heart Disease
    Monika Barteková, Kristína Ferenczyová, Marek Jelemenský, Naranjan S. Dhalla · 2019 · Springer eBooks
  42. Febuxostat facilitates neovasculogenesis in chronic kidney disease through xanthine oxidase/NADPH oxidase/c-Jun signaling pathways
    Hsin-Jou Lee, Chih‐Hung Chiang, Jung-Hung Hsieh, Su-Chu Lin, Jaw‐Wen Chen, Ting‐Ting Chang · 2025 · Biomedicine & Pharmacotherapy
  43. Influence of Uric Acid on Vascular and Cognitive Functions: Evidence for an Ambivalent Relationship
    Francesco Baratta, Federica Moscucci, Evaristo Ettorre, Raffaella Bocale, Arrigo F.G. Cicero, Pietro Cirillo, Federica Fogacci, Ilaria Lospinuso, Carmine Savoia, Alessandro Mengozzi et al. · 2024 · Metabolites
  44. Syntheses, Crystal Structures and Xanthine Oxidase Inhibitory Activity of Aroylhydrazones
    Yong-Jun Han · 2022 · Acta chimica slovenica
  45. Probenecid and Eugenol Mitigate Testosterone Induced Benign Prostatic Hyperplasia by Targeting Uric Acid‐Induced Inflammation and Pro‐Survival Pathways
    Nibrass Taher Abdali, Yasmin S. Mohamed, Hala Fahmy Zaki, Laila A. A. Ramadan, Hassan Afify · 2025 · The Prostate
  46. Redox Proteomics Analysis of Atherosclerotic Aortas: Application of the “OxICAT” Method
    Manousos Makridakis, Antonia Vlahou · 2022 · Methods in molecular biology
  47. 3,4,5-Trihydroxycinnamic Acid Inhibits LPS-Induced Inflammatory Response by Increasing SIRT1 Expression in Human Umbilical Vein Endothelial Cells
    Jinyoung Park, Hee Jae Lee, Yong-Soo Kwon, Wanjoo Chun · 2020 · Journal of Vascular Research
  48. Modern paradigm of treatment of hyperuricemia and gout in comorbid patients with the development of cardio-vascular pathology
    Mazurov Vi, Irina B. Belyaeva, М. С. Петрова, R. A. Bashkinov · 2020 · Meditsinskiy sovet = Medical Council
  49. Environmental and dietary triggers of hyperuricemia in chronic kidney disease: A cardiovascular perspective
    Mohammed AbuBaha, Anwar Zahran, Ahmad Nouri, Mohammad Bdair, Husam Hamshary, Hasan Fuqha, Bara Abubaha, Fathalla Noori, Ayman Khaled, Ameer Awashra et al. · 2026 · European Journal of Clinical Investigation
  50. Commercial and non-commercial cyclodextrin derivatives as a novel therapy to improve gout’s disease and hyperuricemia
    Adrián Matencio, Yousef Khazaei Monfared, Fabrizio Caldera, Mohammad Mahmoodian, Manuel López-Nicolás, Parvin Zakeri‐Milani, Roberta Cavalli, Francesco Trotta · 2025 · International Journal of Pharmaceutics
  51. Chronic hyperglycemia may attenuate the serum-uric-acid-lowering effect of low-dose febuxostat in Japanese patients with type 2 diabetes mellitus
    Yoshiyuki Bando, Hitomi Toyama, Hideo Kanehara, Azusa Hisada, Kazuhiro Okafuji, Daisyu Toya, Nobuyoshi Tanaka · 2016 · Diabetology International
  52. Uric Acid as a Biomarker in Nutritional Metabolism
    Tomislav Bulum · 2022 · Biomarkers in disease
  53. Syntheses, Characterization, Crystal Structures and Xanthine Oxidase Inhibitory Activity of Hydrazones
    Xiao‐Jun Zhao, Ling‐Wei Xue, Qiao-Ru Liu · 2023 · Acta chimica slovenica
  54. Febuxostat Improves Postprandial Glucose Regulation and Insulin Sensitivity in Hyperuricemic Individuals with Prediabetes or Newly Diagnosed Type 2 Diabetes: A Prospective Cohort Study
    S. Liu, Qingsong Liu, Ronger Gu, Mian Wu, Shuo Meng, Yan Le, Qi Chen, Cuiling Zhu, Si Chen, Bei Xu et al. · 2025 · Drug Design Development and Therapy
  55. Sustained xanthine oxidase inhibitor treat to target urate lowering therapy rewires a tight inflammation serum protein interactome
    Concepcion Sanchez, Anamika Campeau, Ru Liu‐Bryan, Ted R. Mikuls, James R. O’Dell, David J. Gonzalez, Robert A. Terkeltaub · 2024 · Research Square
  56. Oxidative Stress-Associated Pathology: A Review (Patologi berkaitan Tekanan Oksidatif: Suatu Kajian)
    Sarawoot Palipoch, Phanit Koomhin · 2015
  57. Hyperuricemia: From the Evolution of Species to Cardiovascular Risk
    Fulvio Floccari, Luca Di Lullo, Rodolfo Fernando Rivera, Alberto Santoboni, Andréa Stella, Moreno Malaguti · 2016 · Giornale di Techniche Nefrologiche e Dialitiche
  58. Reaktive Sauerstoffspezies und Gefäßdegeneration
    Jan‐Philipp Minol, Isabella Reinsch, Maximilian Luik, Anne Leferink, Mareike Barth, Alexander Assmann, A. Lichtenberg, Payam Akhyari · 2018 · Zeitschrift für Herz- Thorax- und Gefäßchirurgie
  59. Comorbidities in Gout
    Lisa K. Stamp, Melanie Birger Morillon, Peter T. Chapman · 2018 · Elsevier eBooks
  60. Some opportunities of using xanthine oxidase inhibitors
    Olga V. Zhelyabina, М. С. Елисеев · 2019 · Modern Rheumatology Journal
  61. Hyperuricemia as a risk factor for increase severity of coronary vessel occlusion disease: a cross-sectional study in North Indian population
    Gaurav Singhal, Shilpa Bhardwaj, Ashok Kumar Ahirwar, Harish Chandra Sharma · 2020 · International Journal of Research in Medical Sciences
  62. In-Silico Analysis of Secondary Metabolites that Modulates Enzymes of Cholesterol Target
    Rishab Marahatha, Saroj Basnet, Bibek Raj Bhattarai, Prakriti Budhathoki, Babita Aryal, Bikash Adhikari, Ganesh Lamichhane, Darbin Kumar Poudel, Niranjan Parajuli · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  63. Iperuricemia: dall'evoluzione della specie al rischio cardiovascolare
    Fulvio Floccari, Luca Di Lullo, Rodolfo Fernando Rivera, Alberto Santoboni, Andrea Stella, Moreno Malaguti · 2016 · Giornale di Clinica Nefrologica e Dialisi
  64. Pd-Ia exerts anti-inflammatory effects by activating PPAR-α in human umbilical vein endothelial cells
    Chang H, Jia-Long Zhang, Yang C, Qi Zhou · 2019 · Journal of Translational Science
  65. Characteristics Of Endothelial Dysfunction In Patients With Gout Comorbid With Arterial Hypertension
    N. A. Zolotariova, M. I. Romanchenko, А. П. Боровик · 2016 · DOAJ (DOAJ: Directory of Open Access Journals)
  66. Association of the plasma xanthine oxidoreductase activity with the metabolic parameters and vascular complications in patients with type 2 diabetes: a cross-sectional study in a hospital setting
    Tomoko Okuyama, Jun Shirakawa, Takashi Nakamura, Takayo Murase, Daisuke Miyashita, Ryota Inoue, Mayu Kyohara, Yu Togashi, Yasuo Terauchi · 2020 · Research Square
  67. Uric Acid as a Biomarker in Nutritional Metabolism
    Tomislav Bulum · 2022 · Biomarkers in disease
  68. A hyperurikaemia mint kardiovaszkuláris rizikófaktor és annak befolyásolási lehetőségei
    Nikolett Gajdán, György Ábrahám · 2022 · Cardiologia Hungarica
  69. GOUT AND HYPERURICEMIA AS ADDITIONAL FACTORS OF DETERIORATION OF CARDIAC AND RENAL PATHOLOGIES
    І.О. Снігурська, В.В. Божко, D.К. Miloslavsky, Т. Г. Старченко · 2022 · Bulletin of Problems Biology and Medicine
  70. Cardiovascular safety of xanthine oxidase inhibitors: an optimistic and unfinished story
    М. С. Елисеев, Olga V. Zhelyabina · 2023 · Modern Rheumatology Journal
  71. The effect of uric acid-lowering therapy on vascular stiffness in patients with gout
    Wooseong Jeong, Jinseok Kim · 2025 · Journal of Medicine and Life Science
  72. Attenuation of xanthine oxidase activity: A hypothesis for limiting reactive oxygen species-induced vascular damage in patients with β-thalassemia
    Egarit Noulsri, Surada Lerdwana · 2025 · Medical Hypotheses
  73. Research Progress of UHR and Coronary Heart Disease
    雪萌 王 · 2025 · Asian Case Reports in Emergency Medicine
  74. Molecular mechanisms of reactive oxygen species and regulation of gene expression in cardiometabolic syndrome
    Martyna Fronczek, Maciej Banach, Marcin Goławski, Tadeusz Osadnik · 2025 · Elsevier eBooks
  75. Serum xanthine oxidoreductase and oxidative stress are associated with bladder cancer: a case-control study from Jordan
    Lina Elsalem, Abrar A. Aleikish, Nosayba Zakariya Al‐Azzam, Mahmoud A. Alfaqih, Haneen A. Basheer, Omar Halalsheh · 2025 · Journal of Applied Biomedicine
  76. Additional file 3 of Xanthine oxidase inhibitor urate-lowering therapy titration to target decreases serum free fatty acids in gout and suppresses lipolysis by adipocytes
    Mónica Gumá, Benyamin Dadpey, Roxana Coras, Mikuls, Ted R., Bartlett C. Hamilton, Oswald Quehenberger, Hilda Thorisdottir, David Bittleman, Kimberly Lauro, Reilly, Shannon M. et al. · 2022 · Figshare
  77. Additional file 1 of Xanthine oxidase inhibitor urate-lowering therapy titration to target decreases serum free fatty acids in gout and suppresses lipolysis by adipocytes
    Mónica Gumá, Benyamin Dadpey, Roxana Coras, Mikuls, Ted R., Bartlett C. Hamilton, Oswald Quehenberger, Hilda Thorisdottir, David Bittleman, Kimberly Lauro, Reilly, Shannon M. et al. · 2022 · Figshare
  78. Effect of uric acid-lowering treatment on vascular health and influence of different drug regimens
    Xinyu Zhao, Caitong Zhao, Xiangdong Jiang, Shengkai Ye, Hualin Zhang, Yupeng Liu, Chengli Tao, Renzheng Chen, Dengke Liu · 2026 · European journal of medical research
  79. Integrating crystal engineering with PEG6000 conjugation to formulate advanced solid dispersions of febuxostat for gout management
    Doriana T. Ungur, Laura Pătraș, Mihaela Maria Pop, Coca Iordache, Tudor Tămaş, Alice Mija, Manuela Banciu · 2026 · Journal of Pharmacy and Pharmacology
  80. Insights into the biological effects of molybdenum in an insect model (Galleria mellonella)
    Brianna Hofman, Logan Florek, Sarah Atang, Amani A. Gillette, Babasola A. Fateye, Maria Paula Kwesiga · 2026 · Frontiers in Bioengineering and Biotechnology
  81. Topical febuxostat attenuates imiquimod-induced psoriasiform dermatitis and modulates NFE2L2 (NRF2)/NLRP3 mRNA expression
    Hassan Thoulfikar A. Alameer, Waleed Khaled Younis Albahadly, Haider F. S. Al-Zubaidy, Ahmed Salih Sahib, Meeqaat H. Altrufi, Najah Hamza · 2026 · Pharmacia